Convexia Wants to Buy Drugs, Run Trials, and Sell for Profit Using AI Agents
Traditional pharma takes a decade and $2 billion to bring a drug to market. Convexia uses AI agents to source overlooked drug candidates, run computational trials, and move 10x faster than incumbents.
